Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 110

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity

Fusco, Giuliana, De Simone, Alfonso, Arosio, Paolo, Vendruscolo, Michele, Veglia, Gianluigi, Dobson, Christopher M. · 2016 · Scientific Reports

Abstract

A detailed characterisation of the molecular determinants of membrane binding by α-synuclein (αS), a 140-residue protein whose aggregation is associated with Parkinson’s disease, is of fundamental significance to clarify the manner in which the balance between functional and dysfunctional processes are regulated for this protein. Despite its biological relevance, the structural nature of the membrane-bound state αS remains elusive, in part because of the intrinsically dynamic nature of the protein and also because of the difficulties in studying this state in a physiologically relevant environment. In the present study we have used solid-state NMR and restrained MD simulations to refine structure and topology of the N-terminal region of αS bound to the surface of synaptic-like membranes. This region has fundamental importance in the binding mechanism of αS as it acts as to anchor the protein to lipid bilayers. The results enabled the identification of the key elements for the biological properties of αS in its membrane-bound state.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep27125

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 56

  1. Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949–953 (2012). · DOI · Paper page
  2. Uversky, V. N. & Eliezer, D. Biophysics of Parkinson’s disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci 10, 483–499 (2009). · DOI · Paper page
  3. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid and human disease. Annu Rev Biochem 75, 333–366 (2006). · DOI · Paper page
  4. Luth, E. S., Stavrovskaya, I. G., Bartels, T., Kristal, B. S. & Selkoe, D. J. Soluble, prefibrillar alpha-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction. J Biol Chem 289, 21490–21507 (2014). · DOI · Paper page
  5. Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat Rev Neurol 9, 13–24 (2013). · DOI · Paper page
  6. Bosco, D. A. et al. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol 2, 249–253 (2006). · DOI · Paper page
  7. Ikenoue, T. et al. Cold denaturation of alpha-synuclein amyloid fibrils. Angew Chem Int Ed Engl 53, 7799–7804 (2014). · DOI
  8. Paslawski, W., Mysling, S., Thomsen, K., Jorgensen, T. J. & Otzen, D. E. Co-existence of two different alpha-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry. Angew Chem Int Ed Engl 53, 7560–7563 (2014). · DOI
  9. Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047 (1997). · DOI · Paper page
  10. Singleton, A. B. et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841 (2003). · DOI · Paper page
  11. Barbour, R. et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5, 55–59 (2008). · DOI · Paper page
  12. Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8, 2804–2815 (1988). · DOI · Paper page
  13. Auluck, P. K., Caraveo, G. & Lindquist, S. alpha-Synuclein: membrane interactions and toxicity in Parkinson’s disease. Annu Rev Cell Dev Biol 26, 211–233 (2010). · DOI · Paper page
  14. Cooper, A. A. et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models. Science 313, 324–328 (2006). · DOI · Paper page
  15. Vargas, K. J. et al. Synucleins regulate the kinetics of synaptic vesicle endocytosis. J Neurosci 34, 9364–9376 (2014). · DOI · Paper page
  16. Soper, J. H. et al. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol Biol Cell 19, 1093–1103 (2008). · DOI
  17. Maltsev, A. S., Ying, J. & Bax, A. Impact of N-terminal acetylation of alpha-synuclein on its random coil and lipid binding properties. Biochemistry 51, 5004–5013 (2012). · DOI · Paper page
  18. Bodner, C. R., Dobson, C. M. & Bax, A. Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. J Mol Biol 390, 775–790 (2009). · DOI · Paper page
  19. Snead, D. & Eliezer, D. Alpha-synuclein function and dysfunction on cellular membranes. Exp Neurobiol 23, 292–313 (2014). · DOI · Paper page
  20. Lee, H. J., Choi, C. & Lee, S. J. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277, 671–678 (2002). · DOI · Paper page
  21. Dedmon, M. M., Lindorff-Larsen, K., Christodoulou, J., Vendruscolo, M. & Dobson, C. M. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc 127, 476–477 (2005). · DOI · Paper page
  22. Fusco, G. et al. Direct observation of the three regions in alpha-synuclein that determine its membrane-bound behaviour. Nat Commun 5, 3827 (2014). · DOI · Paper page
  23. Bodner, C. R., Maltsev, A. S., Dobson, C. M. & Bax, A. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson’s disease revealed by solution NMR spectroscopy. Biochemistry 49, 862–871 (2010). · DOI · Paper page
  24. Maltsev, A. S., Chen, J., Levine, R. L. & Bax, A. Site-specific interaction between alpha-synuclein and membranes probed by NMR-observed methionine oxidation rates. J Am Chem Soc 135, 2943–2946 (2013). · DOI
  25. Wang, G. F., Li, C. & Pielak, G. J. 19F NMR studies of alpha-synuclein-membrane interactions. Protein Sci 19, 1686–1691 (2010). · DOI
  26. Ulmer, T. S., Bax, A., Cole, N. B. & Nussbaum, R. L. Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem 280, 9595–9603 (2005). · DOI · Paper page
  27. Lokappa, S. B. & Ulmer, T. S. Alpha-synuclein populates both elongated and broken helix states on small unilamellar vesicles. J Biol Chem 286, 21450–21457 (2011). · DOI
  28. Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S. & Langen, R. Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci USA 105, 19666–19671 (2008). · DOI · Paper page
  29. Bartels, T. et al. The N-terminus of the intrinsically disordered protein alpha-synuclein triggers membrane binding and helix folding. Biophys J 99, 2116–2124 (2010). · DOI · Paper page
  30. Kohlhoff, K. J., Robustelli, P., Cavalli, A., Salvatella, X. & Vendruscolo, M. Fast and accurate predictions of protein NMR chemical shifts from interatomic distances. J Am Chem Soc 131, 13894–13895 (2009). · DOI · Paper page
  31. Robustelli, P., Kohlhoff, K., Cavalli, A. & Vendruscolo, M. Using NMR chemical shifts as structural restraints in molecular dynamics simulations of proteins. Structure 18, 923–933 (2010). · DOI · Paper page
  32. Shen, Y. & Bax, A. SPARTA+: a modest improvement in empirical NMR chemical shift prediction by means of an artificial neural network. J Biomol NMR 48, 13–22 (2010). · DOI · Paper page
  33. Camilloni, C., De Simone, A., Vranken, W. F. & Vendruscolo, M. Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. Biochemistry 51, 2224–2231 (2012). · DOI · Paper page
  34. Wang, C., Shah, N., Thakur, G., Zhou, F. & Leblanc, R. M. Alpha-synuclein in alpha-helical conformation at air-water interface: implication of conformation and orientation changes during its accumulation/aggregation. Chem Commun (Camb) 46, 6702–6704 (2010). · doi:10.1039/c0cc02098b
  35. De Simone, A., Mote, K. R. & Veglia, G. Structural dynamics and conformational equilibria of SERCA regulatory proteins in membranes by solid-state NMR restrained simulations. Biophys J 106, 2566–2576 (2014). · DOI · Paper page
  36. Magzoub, M., Eriksson, L. E. & Graslund, A. Conformational states of the cell-penetrating peptide penetratin when interacting with phospholipid vesicles: effects of surface charge and peptide concentration. Biochim Biophys Acta 1563, 53–63 (2002). · DOI · Paper page
  37. Ashworth Briggs, E. L. et al. Interaction between the NS4B amphipathic helix, AH2 and charged lipid headgroups alters membrane morphology and AH2 oligomeric state–implications for the hepatitis C virus life cycle. Biochim Biophys Acta 1848, 1671–1677 (2015). · DOI
  38. Gustavsson, M. et al. Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban. Proc Natl Acad Sci USA 110, 17338–17343 (2013). · DOI · Paper page
  39. Vicari, C. et al. Artificial heme-proteins: determination of axial ligand orientations through paramagnetic NMR shifts. Chem Commun (Camb) 50, 3852–3855 (2014). · doi:10.1039/c3cc49123d
  40. Vamvaca, K., Volles, M. J. & Lansbury, P. T., Jr. The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast. J Mol Biol 389, 413–424 (2009). · DOI
  41. Gitler, A. D. et al. The Parkinson’s disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci USA 105, 145–150 (2008). · DOI · Paper page
  42. Diao, J. et al. Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2. Elife 2, e00592 (2013). · DOI · Paper page
  43. Nemani, V. M. et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66–79 (2010). · DOI · Paper page
  44. Wislet-Gendebien, S. et al. Cytosolic proteins regulate alpha-synuclein dissociation from presynaptic membranes. J Biol Chem 281, 32148–32155 (2006). · DOI
  45. Cookson, M. R. The biochemistry of Parkinson’s disease. Annu Rev Biochem 74, 29–52 (2005). · DOI · Paper page
  46. Rodriguez, J. A. et al. Structure of the toxic core of alpha-synuclein from invisible crystals. Nature 525, 486–490 (2015). · DOI · Paper page
  47. Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein. Nat Struct Mol Biol, 23, 409–15 (2016). · DOI · Paper page
  48. Takegoshi, K. & Terao, T. 13C-1H dipolar recoupling under very fast magic-angle spinning using virtual pulses. Solid State Nucl Magn Reson 13, 203–212 (1999). · doi:10.1016/s0926-2040(99)00005-3
  49. Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E. GROMACS 4: Algorithms for highly efficient, load-balanced and scalable molecular simulation. J Chem Theor Comput 4, 435–447 (2008). · DOI · Paper page
  50. Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950–1958 (2010). · DOI · Paper page
  51. Horn, H. W. et al. Development of an improved four-site water model for biomolecular simulations: TIP4P-Ew. J Chem Phys 120, 9665–9678 (2004). · DOI · Paper page
  52. Jambeck, J. P. & Lyubartsev, A. P. Derivation and systematic validation of a refined all-atom force field for phosphatidylcholine lipids. J Phys Chem B 116, 3164–3179 (2012). · DOI · Paper page
  53. Hess, B., Bekker, H., Berendsen, H. W. & Fraaije, J. G. LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18, 1463–1472 (1997). · DOI · Paper page
  54. Darden, T., Perera, L., Li, L. & Pedersen, L. New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure 7, R55–60 (1999). · DOI · Paper page
  55. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J Chem Phys 126, 014101 (2007). · DOI · Paper page
  56. Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577–2637 (1983). · DOI · Paper page

Cited by

See all 110

Metadata

Authors
Fusco, G., De Simone, A., Arosio, P., Vendruscolo, M., Veglia, G., & Dobson, C. M.
Venue
Scientific Reports
Published
2016-06-08
Volume
6
Issue
1
ISSN
2045-2322
Cited by
110
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.